Lorenzo-Redondo et al. reply

Affiliations

¹ Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60011, USA.
² Institute for Emerging Infections, Department of Zoology, University of Oxford, Oxford OX1 3PS, UK.
³ Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
⁴ Centro de Investigação em Biodiversidade e Recursos Genéticos Universidade do Porto, Campus de Vairão, Rua Padre Armando Quintas 4485-661 Vairão, Portugal.
⁵ Institute for Genomics and Evolutionary Medicine, Temple University, Philadelphia, Pennsylvania 19122, USA.
⁶ Division of Viral Diseases, Center for Laboratory Control of Infectious Diseases, Korea Centers for Disease Control and Prevention, Chungju-si, Chungcheongbuk-do, 28159, South Korea.
⁷ Department of Surgery, University of Minnesota, Minneapolis, Minnesota 55455, USA.
⁸ Antiviral Pharmacology Laboratory, University of Nebraska Medical Center, College of Pharmacy, Omaha, Nebraska 68198, USA.
⁹ Division of Infectious Diseases, University of Minnesota, Minneapolis, Minnesota 55455, USA.
¹⁰ Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, Guy's Hospital, London SE1 9RT, UK.
¹¹ Institute of Evolutionary Biology, University of Edinburgh, Edinburgh EH9 3FL, UK.
¹² Department of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota 55455, USA.

Ramon Lorenzo-Redondo et al. Nature. 2017.

. 2017 Nov 22;551(7681):E10.

doi: 10.1038/nature24635.

¹ Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60011, USA.
² Institute for Emerging Infections, Department of Zoology, University of Oxford, Oxford OX1 3PS, UK.
³ Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
⁴ Centro de Investigação em Biodiversidade e Recursos Genéticos Universidade do Porto, Campus de Vairão, Rua Padre Armando Quintas 4485-661 Vairão, Portugal.
⁵ Institute for Genomics and Evolutionary Medicine, Temple University, Philadelphia, Pennsylvania 19122, USA.
⁶ Division of Viral Diseases, Center for Laboratory Control of Infectious Diseases, Korea Centers for Disease Control and Prevention, Chungju-si, Chungcheongbuk-do, 28159, South Korea.
⁷ Department of Surgery, University of Minnesota, Minneapolis, Minnesota 55455, USA.
⁸ Antiviral Pharmacology Laboratory, University of Nebraska Medical Center, College of Pharmacy, Omaha, Nebraska 68198, USA.
⁹ Division of Infectious Diseases, University of Minnesota, Minneapolis, Minnesota 55455, USA.
¹⁰ Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, Guy's Hospital, London SE1 9RT, UK.
¹¹ Institute of Evolutionary Biology, University of Edinburgh, Edinburgh EH9 3FL, UK.
¹² Department of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota 55455, USA.

No abstract available

Comment on

1. Rosenbloom DIS, Hill AL, Laskey SB & Siliciano RF Re-evaluating evolution in the HIV reservoir. Nature 551, 10.1038/nature24634 (2017). - DOI - PMC - PubMed
1. Lorenzo-Redondo R, et al. Persistent HIV-1 replication maintains the tissue reservoir during therapy. Nature 530, 51–56 (2016). - PMC - PubMed
1. Rambaut A, Posada D, Crandall KA & Holmes EC The causes and consequences of HIV evolution. Nat. Rev. Genet. 5, 52–61 (2004). - PubMed
1. Lemey P, Rambaut A & Pybus OG HIV evolutionary dynamics within and among hosts. AIDS Rev. 8, 125–140 (2006). - PubMed
1. Liu Y et al. Selection on the human immunodeficiency virus type 1 proteome following primary infection. J. Virol. 80, 9519–9529 (2006). - PMC - PubMed